Meet the Editors | PLOS Complex Systems
Find out who's leading complex systems research at PLOS as we learn more about the experts on the newly formed editorial board.
Stay updated with breaking news from Biomedical Data Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Find out who's leading complex systems research at PLOS as we learn more about the experts on the newly formed editorial board.
Topline data from the randomized Phase 2b KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer expected in early April 2024 Median progression free survival of...
Topline data from the randomized Phase 2b KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer (NSCLC) expected in early April 2024
A new generative artificial intelligence model developed by researchers at Stanford and McMaster Universities can create billions of new antibiotic molecules that are simple and affordable to produce in the lab.
Topline data from the randomized Phase 2b KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer (NSCLC) expect...